Investigations, Enforcement, & Compliance Alerts

On January 27, 2026, the Trump administration announced what it called “a historic expansion” of the Mexico City Policy, a longstanding U.S. rule restricting foreign aid funding related to abortion. The expansion extends the policy beyond abortion to include activities related to diversity, equity, and inclusion (DEI) and gender‑affirming care. Effective February 26, 2026, the change represents the most significant revision to the policy in its 40‑year history and could substantially reshape the distribution of U.S. foreign assistance worldwide.

The annual False Claims Act (FCA) recovery statistics issued by the U.S. Department of Justice for Fiscal Year 2024, coupled with the Trump administration’s focus on the elimination of waste, fraud, and abuse in government spending and apparent intentions to rely on the FCA to pursue other administration priorities, signal a likely increase in FCA investigations and actions throughout 2025 and beyond.

Earlier this month, the Food and Drug Administration (“FDA” or “the Agency”) issued guidance to clarify how firms in a product distribution chain, including manufacturers and distributors, should establish voluntary-recall initiation procedures that ensure timely identification and notification of and responses to product problems.